Search for: "PACIRA PHARMACEUTICALS INC" Results 1 - 12 of 12
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Oct 2015, 8:50 am by Lisa Baird
As readers of this blog know, following Amarin’s success in obtaining a preliminary injunction limiting FDA enforcement action against it for truthful, non-misleading off-label promotion of its prescription drug Vascepa, Pacira Pharmaceuticals filed a similar lawsuit regarding off-label promotion of its prescription drug Exparel. [read post]
14 Sep 2015, 2:38 pm
  Last year, the FDA issued a warning letter claiming that Pacira Pharmaceuticals, Inc. had engaged in false and misleading promotion and misbranded its non-opioid pain drug, EXPAREL, by promoting it for pain relief in surgeries other than those (hemorrhoids and bunions) for which Pacira had conducted the two clinical trials that won EXPAREL its FDA approval. [read post]
11 Sep 2015, 10:55 am by Lisa Baird
” Taking a page out of the Amarin playbook, Pacira Pharmaceuticals, Inc. has now filed its own lawsuit in the Southern District of New York seeking “to establish its right to speak in a truthful and non-misleading fashion about lawful uses of its product EXPAREL. [read post]